ID   MOPC-315
AC   CVCL_2616
SY   MOPC 315; MOPC315
DR   BTO; BTO:0000581
DR   CLO; CLO_0007830
DR   CLDB; cl3537
DR   ChEMBL-Cells; CHEMBL3307316
DR   ChEMBL-Targets; CHEMBL614178
DR   ECACC; 85022106
DR   PubChem_Cell_line; CVCL_2616
DR   Wikidata; Q54906384
RX   PubMed=207531;
RX   PubMed=8098665;
RX   PubMed=9419351;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: 19 hours (PubMed=207531).
CC   Monoclonal antibody isotype: IgA, lambda.
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
RX   PubMed=207531; DOI=10.1016/0014-2964(78)90008-7;
RA   Yaniv A., Gazit A., Dvir M., Guthmann D., Eylan E.;
RT   "Adaptation of murine MOPC-315 myeloma cells to growth in vitro and
RT   further characterization of their C-type viruses.";
RL   Eur. J. Cancer. 14:771-779(1978).
RX   PubMed=8098665; DOI=10.1006/cimm.1993.1100;
RA   Lauritzsen G.F., Bogen B.;
RT   "The role of idiotype-specific, CD4+ T cells in tumor resistance
RT   against major histocompatibility complex class II molecule negative
RT   plasmacytoma cells.";
RL   Cell. Immunol. 148:177-188(1993).
RX   PubMed=9419351; DOI=10.1073/pnas.95.1.189;
RA   Amoroso S.R., Huang N.-H., Roberts A.B., Potter M., Letterio J.J.;
RT   "Consistent loss of functional transforming growth factor beta
RT   receptor expression in murine plasmacytomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:189-194(1998).